Role of the α2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 6, 2006, Pages

  Zarrinpashneh, Elham ^a   Carjaval, Karla ^c   Beauloye, Christophe ^a   Ginion, Audrey ^a   Mateo, Philippe ^c   Pouleur, Anne Catherine ^a   Horman, Sandrine ^b   Vaulont, Sophie ^d   Hoerter, Jacqueline ^c   Viollet, Benoit ^d   Hue, Louis ^b   Vanoverschelde, Jean Louis ^a   Bertrand, Luc ^a,e  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c IPSIT   (France)

^d INSERM   (France)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Acetyl CoA carboxylase; Glycogen; Glycolysis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENINE NUCLEOTIDE; GLUCOSE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LACTIC ACID; PROTEIN SUBUNIT; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; ADENINE; ADENOSINE TRIPHOSPHATE; AMP ACTIVATED PROTEIN KINASE BETA; AMP-ACTIVATED PROTEIN KINASE BETA; FATTY ACID; ISOENZYME; LACTIC ACID DERIVATIVE; MULTIENZYME COMPLEX; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CHAIN; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; GLYCOLYSIS; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; KNOCKOUT MOUSE; METABOLISM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART CONTRACTION; HEART MUSCLE; MOUSE MUTANT; PHYSIOLOGY;

ACETYL-COA CARBOXYLASE; ADENINE; ADENOSINE TRIPHOSPHATE; ANIMALS; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN; ISOENZYMES; LACTATES; MICE; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHENOTYPE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 33845416894     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01032.2005     Document Type: Article

References (54)

1. Askenasy N. Glycolysis protects sarcolemmal membrane integrity during total ischemia in the rat heart. Basic Res Cardiol 96: 612-622, 2001.
2. Avruch J, Lin Y, Long X, Murthy S, and Ortiz-Vega S. Recent advances in the regulation of the TOR pathway by insulin and nutrients. Curr Opin Clin Nutr Metab Care 8: 67-72, 2005.
3. Beauloye C, Marsin AS, Bertrand L, Krause U, Hardie DG, Vanoverschelde JL, and Hue L. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett 505: 348-352, 2001.
4. Bertrand L, Ginion A, Beauloye C, Hebert A, Guigas B, Hue L, and Vanoverschelde JL. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291: H239-H250, 2006.
5. Bolster DR, Crozier SJ, Kimball SR, and Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277: 23977-23980, 2002.
6. Browne GJ, Finn SG, and Proud CG. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 279: 12220-12231, 2004.
7. Carling D. AMP-activated protein kinase: balancing the scales. Biochimie 87: 87-91, 2005.
8. Cheung PC, Salt IP, Davies SP, Hardie DG, and Carling D. Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem J 346: 659-669, 2000.
9. Clark H, Carling D, and Saggerson D. Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur J Biochem 271: 2215-2224, 2004.
10. Daniel T and Carling D. Expression and regulation of the AMP-activated protein kinase-SNF1 (sucrose nonfermenting 1) kinase complexes in yeast and mammalian cells: studies using chimaeric catalytic subunits. Biochem J 365: 629-638, 2002.
11. Fryer LG, Parbu-Patel A, and Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
12. 2+ current in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). FASEB J 16: 1636-1638, 2002.
13. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117: 5479-5487, 2004.
14. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, and Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887, 1996.
15. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, and Hardie DG. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19, 2005.
16. Horman S, Beauloye C, Vertommen D, Vanoverschelde JL, Hue L, and Rider MH. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J Biol Chem 278: 41970-41976, 2003.
17. Horman S, Browne G, Krause U, Patel J, Vertommen D, Bertrand L, Lavoinne A, Hue L, Proud C, and Rider M. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 12: 1419-1423, 2002.
18. 485/491. J Biol Chem 281: 5335-5340, 2006.
19. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA, Baba O, Terashima T, and Hardie DG. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13: 861-866, 2003.
20. Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin AS, Meisse D, Vertommen D, and Rider MH. New targets of AMP-activated protein kinase. Biochem Soc Trans 31: 213-215, 2003.
21. Hue L, Beauloye C, Marsin AS, Bertrand L, Horman S, and Rider MH. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 34: 1091-1097, 2002.
22. Hue L, Bontemps F, and Hers H. The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J 152: 105-114, 1975.
23. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066, 2005.
24. Inoki K, Zhu T, and Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115: 577-590, 2003.
25. 2 5′-AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53: 3074-3081, 2004.
26. 1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1β,4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279: 1070-1079, 2004.
27. King LM and Opie LH. Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem 180: 3-26, 1998.
28. Kolocassides KG, Galinanes M, and Hearse DJ. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture. Circulation 93: 1725-1733, 1996.
29. Kolocassides KG, Galinanes M, and Hearse DJ. Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am J Physiol Heart Circ Physiol 269: H1415-H1420, 1995.
30. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
31. Lefebvre V, Mechin MC, Louckx MP, Rider MH, and Hue L. Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin. J Biol Chem 271: 22289-22292, 1996.
32. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, and Alessi DR. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23: 833-843, 2004.
33. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, and Hue L. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10: 1247-1255, 2000.
34. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
35. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, and Stapleton D. AMPK β-subunit targets metabolic stress sensing to glycogen. Curr Biol 13: 867-871, 2003.
36. Russell RR III, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
37. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, and Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114: 495-503, 2004.
38. 1. Am J Physiol Endocrinol Metab 290: E780-E788, 2006.
39. Sakoda H, Fujishiro M, Shojima N, Ogihara T, Kushiyama A, Fukushima Y, Anai M, Ono H, Kikuchi M, Horike N, Viana AY, Uchijima Y, Kurihara H, and Asano T. Glycogen debranching enzyme association with β-subunit regulates AMP-activated protein kinase activity. Am J Physiol Endocrinol Metab 289: E474-E481, 2005.
40. 2 isoform. Biochem J 334: 177-187, 1998.
41. Sambandam N and Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42: 238-256, 2003.
42. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, and Kemp BE. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996.
43. Thornton C, Snowden MA, and Carling D. Identification of a novel AMP-activated protein kinase β-subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 273: 12443-12450, 1998.
44. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, and Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol Heart Circ Physiol 267: H1785-H1794, 1994.
45. Ventura-Clapier R and Veksler V. Myocardial ischemic contracture. Metabolites affect rigor tension development and stiffness. Circ Res 74: 920-929, 1994.
46. Vincent MF, Marangos PJ, Gruber HE, and Van den Berghe G. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 40: 1259-1266, 1991.
47. 2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111: 91-98, 2003.
48. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2: 21-33, 2005.
49. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, and Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13: 2004-2008, 2003.
50. 2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397: 347-351, 1996.
51. 2 subunit of AMP-activated protein kinase. J Biol Chem 278: 28372-28377, 2003.
52. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
53. Young LH, Li J, Baron SJ, and Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15: 110-118, 2005.
54. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, and Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.